Zum Hauptinhalt springen

How can I be sure a genetic test is valid and useful?

Before undergoing genetic testing, it is important to be sure that the test is valid and useful. A genetic test is valid if it provides an accurate result. Two main measures of accuracy apply to genetic tests: analytical validity and clinical validity. Another measure of the quality of a genetic test is its usefulness, or clinical utility.

Übersicht

Before undergoing genetic testing, it is important to be sure that the test is valid and useful. A genetic test is valid if it provides an accurate result. Two main measures of accuracy apply to genetic tests: analytical validity and clinical validity. Another measure of the quality of a genetic test is its usefulness, or clinical utility.

  • Analytical validity refers to how well the test predicts the presence or absence of a particular gene or genetic change. In other words, can the test accurately detect whether a specific genetic variant is present or absent?

  • Clinical validity refers to how well the genetic variant being analyzed is related to the presence, absence, or risk of a specific disease.

  • Clinical utility refers to whether the test can provide helpful information about diagnosis, treatment, management, or prevention of a disease.

All laboratories that perform health-related testing for disease prevention, diagnosis, or treatment, including genetic testing, are subject to federal regulatory standards called the Clinical Laboratory Improvement Amendments (CLIA) or even stricter state requirements. CLIA standards cover how tests are performed, the qualifications of laboratory personnel, and quality control and testing procedures for each laboratory. By controlling the quality of laboratory practices, CLIA standards are designed to ensure the analytical validity of genetic tests.

CLIA standards do not address the clinical validity or clinical utility of genetic tests. The Food and Drug Administration (FDA) requires information about clinical validity for some genetic tests, particularly those tests that can influence a person's medical care. Additionally, states may require additional information on clinical validity for laboratory tests performed for people living in that state. Test takers, health care providers, and health insurance companies are often the ones who determine the clinical utility of a genetic test.

It can be difficult to determine the quality of genetic tests sold directly to the public. Some providers of direct-to-consumer genetic tests are not CLIA-certified, and many direct-to-consumer genetic tests are not regulated by the FDA, so it can be difficult to tell whether the tests are valid. If providers of direct-to-consumer genetic tests offer easy-to-understand information about the scientific basis of their tests, it can help people make more informed decisions. It may also be helpful to discuss any concerns with a health care provider before ordering a direct-to-consumer genetic test and after receiving test results.

Related patient information and medicines

Genetische Tests

Patient information leaflet

Genetische Tests

Genetic testing is a type of medical test that identifies changes in chromosomes, genes or proteins. Genetic tests examine a person's DNA in a variety of ways to assess a person's genetic health. They are all designed to identify a particular gene that may cause a genetic disorder. Sometimes a gene... Note : the information below is a general.

BRCA-Gene

Patient information leaflet

BRCA-Gene

There are a few known gene changes (mutations) that can increase the risk of certain cancers, and tests available for some of them, including BRCA1 and BRCA2 gene mutations. See also the separate leaflet on Genetic Testing Genetic testing for further Information. Your genetics specialist will be able to give you a great deal of information so that.

Chorionzottenbiopsie

Patient information leaflet

Chorionzottenbiopsie

Chorionzottenbiopsie (CVS) ist a procedure das is carried out during pregnancy to diagnose or exclude various chromosomal or genetic conditions. Chorionzottenbiopsie (CVS) ist a procedure that is carried out during early pregnancy. Usually the reason is to see if the developing baby has a chromosomal disorder such as Down's syndrome or a.

Down-Syndrom-Screening

Patient information leaflet

Down-Syndrom-Screening

There are two different types of tests that can be done to look for Down's syndrome during pregnancy - a screening test and a diagnostic test. Down's syndrome is a genetic chromosome problem that some people are born with. Down's syndrome may be suspected shortly after birth because of the typical features that a baby with Down's syndrome ....

Thalassämie

Patient information leaflet

Thalassämie

For the more severe forms of thalassaemia, modern treatment gives a good outlook, but lifelong monitoring and treatment are needed. Depending on which type you have, thalassaemia may cause no illness at all, or may be a serious lifelong condition requiring treatment. The cause is an inherited (genetic) change, involving the genes which tell the.

Neugeborenen-Bluttest

Patient information leaflet

Neugeborenen-Bluttest

Mothers of all newborn babies are offered testing for certain rare but serious health conditions by testing blood taken from the baby's heel. This is the blood spot screening programme and it is also known as the heel prick test. This is high in babies with cystic fibrosis. If it is high then a sweat test and genetic test are usually done to.

Weiterführende Lektüre und Referenzen

Nehmen Sie an der Diskussion teil

Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.

Haftungsausschluss: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online-Apotheke, Behandlungen und Gesundheitsdienstleistungen

Einfacher Zugang zu vertrauenswürdigen Behandlungen und Gesundheitsdiensten online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Abonnieren Sie den Patienten-Newsletter

Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.

Bitte geben Sie eine gültige E-Mail-Adresse ein

Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.